Cognitive functioning and GABA(A)/benzodiazepine receptor binding in schizophrenia: A 123I-Iomazenil SPET study

Biological Psychiatry

Volumn 43, Issue 2, 1998, Pages 107-117

  Ball, Suzanne ^c   Busatto, Geraldo F ^d   David, Anthony S ^d   Jones, Steven H ^b   Hemsley, David R ^d   Pilowsky, Lynn S ^a   Costa, Durval C ^a   Ell, Peter J ^a   Kerwin, Robert W ^d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Birch Hill Hospital   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d NONE

Author keywords

Benzodiazepine receptor; GABA; Iomazenil; Neuropsychology; Schizophrenia; SPET

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CHLORPROMAZINE; IODINE 125; IOMAZENIL; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUMAZENIL; RADIOACTIVE IODINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RECEPTOR BINDING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MENTAL DISEASE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; CLINICAL TRIAL; FEMALE; IMAGE PROCESSING; MALE; METABOLISM; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; SCINTISCANNING;

ADULT; COGNITION; FEMALE; FLUMAZENIL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; RECEPTORS, GABA-A; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032518057     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00300-4     Document Type: Article

References (44)

1. Abadie P, Baron JC, Bisserbe JC, Boulenger P, Rioux JM, Travere L, Barre MC, Petit-Taboue MC, Zarifian E (1992): Central benzodiazepine receptors in human brain: estimation of regional Bmax and Kd values with positron emission tomography. Eur J Pharmacol 213:107-115.
2. Abi-Dargham A, Gandelman M, Zoghbi SS, Laruelle M, Baldwin RM, Randall P, Charney DS, Hoffer PB, Innis RB (1995): Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. J Nucl Med 36:167-175.
3. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG (1995): Gene Expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258-266.
4. Andreasen NC (1982): Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39:784-788.
5. Annett M (1970): A classification of hand preference by association analysis. Br J Psychol 61:303-321.
6. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
7. Bartenstein P, Ludolph A, Schober O, Lottes G, Scheidhauer K, Sciuk J, Beer HF (1991): Benzodiazepine receptors and cerebral blood flow in partial epilepsy. Eur J Nucl Med 18:111-118.
8. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12:924-929.
9. 123I-Iomazenil single photon emission tomography (SPET). Eur J Nucl Med 22:12-16.
10. Busatto GF, Pilowsky LS, Costa DC, Ell PJ, David AS, Lucey JV, Kerwin RW (1997): Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. Am J Psychiatry 154:56-63.
11. Cassady SL, Thaker GK, Moran M, Birt A, Tamminga CA (1992): GABA agonist-induced changes in motor, oculomotor and attention measures correlate in schizophrenics with tardive dyskinesia. Biol Psychiatry 32:302-311.
12. Cohen JD, Servan-Schreiber D (1992): Context, cortex and dopamine: a connectionist approach to behaviour and biology in schizophrenia. Psychol Rev 99:45-77.
13. 99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease - initial results. J Cereb Blood Flow Metab 8:S109-S115.
14. Costa E (1992): Building a bridge between neurobiology and mental illness. J Psychiatr Res 26:449-460.
15. Damasio H, Damasio AR (1989): Lesion Analysis in Neuropsychology. New York: Oxford University Press.
16. Davis KL, Kahn RS, Ko G, Davidson M (1991): Dopamine in schizophrenia: a review and reconceptualisation. Am J Psychiatry 148:1474-1486.
17. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976): The global assessment scale. A procedure form measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766-771.
18. Freund TF, Antal M (1988): GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature 336:170-173.
19. Goldberg TE, Torrey EF, Gold JM, Ragland JD, Bigelow LB, Weinberger DR (1993): Learning and memory in monozygotic twins discordant for schizophrenia. Psychol Med 23:71-85.
20. Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD (1991): The neuropsychology of schizophrenia. Behav Brain Sci 14:1-20.
21. Haefely W, Martin JR, Schoch P (1990): Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11:452-456.
22. 3H]muscimol binding sites in autopsied brains of chronic schizophrenics. Life Sci 40:259-266.
23. van Kammen DP (1977): γ-Aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 139:138-143.
24. van Kammen DP, Kelly M (1991): Dopamine and norepinephrine activity in schizophrenia: an integrative perspective. Schizophr Res 4:173-191.
25. Kaplan RD, Szechtman H, Franco S, Szetchman B, Nahmias C, Garnett ES, List S, Cleghorn JM (1993): Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET). Schizophr Res 11:47-54.
26. Kisvarday ZF, Gulyas A, Beroukas D, North JB, Chubb IW, Somogyi P (1990): Synapses, axonal and dendritic patterns of GABA-immunoreactive neurons in human cerebral cortex. Brain 113:793-812.
27. Liddle PF, Fristen KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RSJ (1992): Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160:179-186.
28. Lukoff D, Liberman RP, Nuechterlein KH (1986): Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 12:578-602.
29. McKenna PJ, Tamlyn D, Lund CE, Mortimer AM, Hammond S, Baddeley AD (1990): Amnesic Syndrome in schizophrenia. Psychol Med 20:967-972.
30. Maziere B, Maziere M (1990): Where have we got to with neuroreceptor mapping of the human brain? Eur J Nucl Med 16:817-35.
31. Nelson HE (1982): The National Adult Reading Test. Windsor: NFER-Nelson.
32. 123I-IBZM single photon emission study. Br J Psychiatry 164:16-26.
33. Reynolds GP, Czudek C, Andrews HB (1990): Deficit and hemispheric asymmetry of GABA reuptake sites in the hippocampus in schizophrenia. Biol Psychiatry 27:1038-44.
34. Roberts E (1972): A hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosci Res Bull 10:469-482.
35. Roxburgh H, Muir WJ, Blackwood DHR, Walker MT, Blackburn IM (1993): Neuropsychological and P300 abnormalities in schizophrenics and their relatives. Psychol Med 23:305-314.
36. Schwartz BD (1990): Early information processing in schizophrenia. Psychiatr Med 8:73-94.
37. Schwartz BL, Rosse RB, Deutsch SI (1992): Toward a neuropsychology of memory in schizophrenia. Psychopharmacol Bull 28:341-351.
38. Simpson MDC, Slater P, Deakin JTW, Royston MC, Skan WJ (1989): Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett 107:211-215.
39. 3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychosis? Neurochem Res 18:219-223.
40. Warrington EK (1988): Recognition Memory Test. Odessa, FL: Psychological Assessment Resources.
41. Wechsler D (1945): Wechsler Memory Scale. New York: The Psychological Corporation.
42. Wechsler D (1981): Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation.
43. Wilson B, Cockburn J, Halligan PW (1987): The Behavioural Inattention Test. Titchfield, Hants: Thames Valley Test Company.
44. Wolkowitz OW, Pickar D (1991): Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. Am J Psychiatry 148:714-726.